ATE486085T1 - Verfahren zur bestimmung des risikos der entwicklung vaskulärer komplikationen bei einem subjekt - Google Patents

Verfahren zur bestimmung des risikos der entwicklung vaskulärer komplikationen bei einem subjekt

Info

Publication number
ATE486085T1
ATE486085T1 AT01925836T AT01925836T ATE486085T1 AT E486085 T1 ATE486085 T1 AT E486085T1 AT 01925836 T AT01925836 T AT 01925836T AT 01925836 T AT01925836 T AT 01925836T AT E486085 T1 ATE486085 T1 AT E486085T1
Authority
AT
Austria
Prior art keywords
risk
subject
determining
vascular complications
developing vascular
Prior art date
Application number
AT01925836T
Other languages
English (en)
Inventor
Andrew Levy
Original Assignee
Rappaport Family Inst For Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/556,469 external-priority patent/US6251608B1/en
Application filed by Rappaport Family Inst For Res filed Critical Rappaport Family Inst For Res
Application granted granted Critical
Publication of ATE486085T1 publication Critical patent/ATE486085T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6862—Ligase chain reaction [LCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT01925836T 2000-04-20 2001-04-19 Verfahren zur bestimmung des risikos der entwicklung vaskulärer komplikationen bei einem subjekt ATE486085T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/556,469 US6251608B1 (en) 2000-04-20 2000-04-20 Method of determining a potential of a hyperglycemic patients of developing vascular complications
US23769600P 2000-10-05 2000-10-05
US09/688,121 US6599702B1 (en) 2000-04-20 2000-10-16 Method of evaluating a risk of a subject of developing vascular complications
PCT/IL2001/000368 WO2001080711A2 (en) 2000-04-20 2001-04-19 Method of evaluating a risk of a subject of developing vascular complications

Publications (1)

Publication Number Publication Date
ATE486085T1 true ATE486085T1 (de) 2010-11-15

Family

ID=27399009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925836T ATE486085T1 (de) 2000-04-20 2001-04-19 Verfahren zur bestimmung des risikos der entwicklung vaskulärer komplikationen bei einem subjekt

Country Status (6)

Country Link
US (1) US6599702B1 (de)
EP (1) EP1276752B1 (de)
AT (1) ATE486085T1 (de)
AU (1) AU5251101A (de)
DK (1) DK1276752T3 (de)
WO (1) WO2001080711A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608393B2 (en) * 2000-04-20 2009-10-27 Rappaport Family Institute For Research In The Medical Sciences Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
CA2512499A1 (en) * 2003-01-02 2004-07-22 Rappaport Family Institute For Research In The Medical Sciences Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
US7610257B1 (en) * 2006-01-10 2009-10-27 Sas Institute Inc. Computer-implemented risk evaluation systems and methods
US8280805B1 (en) 2006-01-10 2012-10-02 Sas Institute Inc. Computer-implemented risk evaluation systems and methods
US7912773B1 (en) * 2006-03-24 2011-03-22 Sas Institute Inc. Computer-implemented data storage systems and methods for use with predictive model systems
US20090074740A1 (en) * 2007-05-14 2009-03-19 Noah Berkowitz Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)
US20090018110A1 (en) * 2007-06-06 2009-01-15 Andrew Levy Haptoglobin genotyping for prognosis and treatment of chronic vasospasm following subarachnoid hemorrhage (SAH)
US8515862B2 (en) * 2008-05-29 2013-08-20 Sas Institute Inc. Computer-implemented systems and methods for integrated model validation for compliance and credit risk
EP2347004B1 (de) 2008-06-13 2016-08-10 Rappaport Family Institute for Research in the Medical Sciences Reagentien und verfahren zum nachweis des polymorphen protein haptoglobin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1010935A7 (nl) * 1997-02-19 1999-03-02 Delanghe Joris Richard Siegfri Fenotypering van humaan haptoglobine in serum of plasma door middel van quantitatieve agglutinatie met streptococcus antigenen.
US6251608B1 (en) * 2000-04-20 2001-06-26 Technion Research & Development Foundation, Ltd. Method of determining a potential of a hyperglycemic patients of developing vascular complications

Also Published As

Publication number Publication date
EP1276752B1 (de) 2010-10-27
WO2001080711A3 (en) 2002-03-28
EP1276752A4 (de) 2007-04-25
US6599702B1 (en) 2003-07-29
EP1276752A2 (de) 2003-01-22
AU5251101A (en) 2001-11-07
WO2001080711A2 (en) 2001-11-01
DK1276752T3 (da) 2011-02-07

Similar Documents

Publication Publication Date Title
AU3084802A (en) Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
DE60131118D1 (de) Verfahren zur schnellen Bestimmung der Annehmbarkeit von zu sterilisierenden Ladungen
DE69219963D1 (de) Verfahren zur bestimmung der zahl lebender mikroorganismen
ATE486085T1 (de) Verfahren zur bestimmung des risikos der entwicklung vaskulärer komplikationen bei einem subjekt
DE60112134D1 (de) Gerät zur Bestimmung eines Belastungspegels vom menschlichen Körper
DE50105937D1 (de) Mehrstufiges Verfahren zur Herstellung von Oxo-Aldehyden und/oder Alkoholen
DE50113565D1 (de) Optoelektronisches bauelement und verfahren zur herstellung
DE60143407D1 (de) Verfahren und vorrichtung zur bestimmung des verschleisszustandes eines reifens
DE602004006793D1 (de) Tastenfolie und Verfahren zur Herstellung derselben
DE60126795D1 (de) Verfahren und Kit zur Bestimmung der geographischen bzw. populationsmässigen Herkunft von Menschen
DE60141806D1 (de) Silikongummi in form eines feinverteilten puders sowie verfahren zur herstellung und verwendung desselben
DE60143831D1 (de) Massgeschneidertes rohteil und verfahren zur herstellung des teiles
DE60111165D1 (de) Verfahren zur Herstellung eines Glasmatrixverbundwerkstoffes und Glasmatrixverbundwerkstoff
DE60031821D1 (de) Rundstrickware und Verfahren zur Herstellung eines Artikels daraus
ATE478062T1 (de) Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid
DE60331705D1 (de) Auswuchtgewicht für Räder und Verfahren zur Herstellung
DE60106717D1 (de) Verfahren und Vorrichtung zur Bestimmung des Skalenfaktors eines Audiosignalkodierers
DE60231739D1 (de) Blech aus ferritischem nichtrostendem stahl mit hervorragender pressformbarkeit und bearbeitbarkeit und verfahren zu seiner herstellung
DE60121508D1 (de) Wegwerfwindeln und Verfahren zu seiner Herstellung
EP0740523A4 (de) Anordnung und verfahren zur bestimmung des schwellwertes des pupillen-reflexes
DE60138512D1 (de) Verfahren zur Herstellung eines Stents
DE60236823D1 (de) Verfahren und Vorrichtung zur Bestimmung des Vorliegens oder Nichtvorliegens eines Flüssigkeitslecks
DE10192921D2 (de) Verfahren zur Herstellung eines Brillenglases
DE50104893D1 (de) Verfahren und vorrichtung zur bestimmung der dicke von transparenten organischen schichten
DE69810086D1 (de) Methode und testkit zur bestimmung des phenotyps eines haptoglobins und anwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties